Determining factors of the response to hyperhomocysteinemia treatment in renal transplant patients

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 3785-3787

  Diaz J M ^a   Sainz, Z ^a   Gich, I ^a   Guirado, L L ^a   Puig, T ^a   Oliver, A ^a   Montanes R ^a   Facundo, C ^a   Chuy, E ^a   Sola R ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; VITAMIN B GROUP;

ADULT; AMINO ACID BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; INFLAMMATORY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; PROTEIN METABOLISM; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; ROC CURVE; TREATMENT OUTCOME; VITAMIN B 12;

EID: 29544444035     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.055     Document Type: Conference Paper

References (9)

1. U.S. Renal Data System: USRDS 2000, Annual Report, 2000
2. B.L. Kasiske Epidemiology of cardiovascular disease after renal transplantation Transplantation 72 2001 S5
3. C.J. Boushey, S.A. Beresford, G.S. Omenn A quantitative assessment of plasma homocysteine as a risk factor for vascular disease JAMA 274 1995 1049
4. D. Ducloux, C. Ruedin, R. Gibey Prevalence, determinants, and clinical significance of hyperhomocysteinemia in renal-transplant recipients Nephrol Dial Transplant 13 1998 2890
5. M. Arnadottir, B. Hultberg, J. Wahlberg Serum total homocysteine concentration before and after renal transplantation Kidney Int 54 1998 1380
6. P.M. Ueland, H. Refsom Plasma homocysteine, a risk factor for vascular disease plasma levels in health, disease, and drug therapy J Lab Clin Med 114 1989 473
7. J. Manrique, P. Errasti, J. Lavilla Treatment of hyperhomocysteinemia after renal transplantation Transplant Proc 35 2003 1742
8. D. Ducloux, G. Motte, B. Challier Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients a prospective study J Am Soc Nephrol 11 2000 134
9. A.S. De Vriese, F. Verbeke, B.F. Schrijvers Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? Kidney Int 61 2002 1199